Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2026)
Hims & Hers Health (HIMS) posted Cost of Revenue of $211.3 million for Q1 2026, up 21.88% sequentially from $173.4 million in Q4 2025, and up 36.05% YoY from $155.3 million in Q1 2025.
Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Cost of Revenue for 7 years, with the latest figure at $211.3 million in Q1 2026.
- Quarterly Cost of Revenue rose 36.05% year-over-year to $211.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $834.7 million (up 18.63% YoY) and the FY2025 annual result came in at $614.3 million, down 9.51% from the prior year.
- Cost of Revenue improved to $211.3 million in Q1 2026 per HIMS's latest filing, from $173.4 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $331.9 million in Q4 2023 and troughed at -$68.9 million in Q4 2022.
- A 5-year average of $131.8 million and a median of $144.9 million in 2024 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2023: Cost of Revenue sank 404.64% in 2022, then surged 582.12% in 2023.
- Over 5 years, Cost of Revenue stood at -$68.9 million in 2022, then soared by 582.12% to $331.9 million in 2023, then slumped by 33.4% to $221.1 million in 2024, then retreated by 21.58% to $173.4 million in 2025, then grew by 21.88% to $211.3 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $211.3 million, $173.4 million, and $232.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 272.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 272.41 Mn |
| Jun 30, 2026 | 272.41 Mn |
| Mar 31, 2026 | 211.32 Mn |
| Mar 31, 2026 | 211.32 Mn |
| Dec 31, 2025 | 173.38 Mn |
| Dec 31, 2025 | 173.38 Mn |
| Sep 30, 2025 | 232.15 Mn |
| Sep 30, 2025 | 232.15 Mn |
| Jun 30, 2025 | 217.86 Mn |
| Jun 30, 2025 | 217.86 Mn |
| Mar 31, 2025 | 155.32 Mn |
| Mar 31, 2025 | 155.32 Mn |
| Dec 31, 2024 | 221.09 Mn |
| Dec 31, 2024 | 221.09 Mn |
| Sep 30, 2024 | 182.28 Mn |
| Sep 30, 2024 | 182.28 Mn |
| Jun 30, 2024 | 144.92 Mn |
| Jun 30, 2024 | 144.92 Mn |
| Mar 31, 2024 | 130.55 Mn |
| Mar 31, 2024 | 130.55 Mn |